tiprankstipranks
Trending News
More News >
COSMOS Pharmaceutical Corporation (JP:3349)
:3349
Japanese Market
Advertisement

COSMOS Pharmaceutical Corporation (3349) Financial Statements

Compare
0 Followers

COSMOS Pharmaceutical Corporation Financial Overview

COSMOS Pharmaceutical Corporation's market cap is currently ¥719.26B. The company's EPS TTM is ¥108.95; its P/E ratio is 23.33; and it has a dividend yield of 0.77%. COSMOS Pharmaceutical Corporation is scheduled to report earnings on July 11, 2025, and the estimated EPS forecast is ¥110.34. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 1.01T¥ 964.99B¥ 827.70B¥ 755.41B¥ 726.42B
Gross Profit¥ 213.28B¥ 188.31B¥ 168.72B¥ 151.45B¥ 145.11B
Operating Income¥ 40.40B¥ 31.50B¥ 30.13B¥ 29.80B¥ 33.15B
EBITDA¥ 64.86B¥ 53.74B¥ 50.19B¥ 48.21B¥ 46.93B
Net Income¥ 30.98B¥ 24.45B¥ 23.80B¥ 23.16B¥ 27.16B
Balance Sheet
Cash & Short-Term Investments¥ 57.04B¥ 52.30B¥ 45.93B¥ 37.36B¥ 55.11B
Total Assets¥ 524.75B¥ 476.55B¥ 420.97B¥ 363.05B¥ 341.32B
Total Debt¥ 49.96B¥ 34.06B¥ 18.20B¥ 9.41B¥ 10.44B
Net Debt¥ -7.08B¥ -18.24B¥ -27.73B¥ -27.95B¥ -44.66B
Total Liabilities¥ 267.29B¥ 245.10B¥ 209.90B¥ 172.54B¥ 170.74B
Stockholders' Equity¥ 257.46B¥ 231.44B¥ 211.07B¥ 190.51B¥ 170.58B
Cash Flow
Free Cash Flow¥ -859.00M¥ -635.00M¥ 7.80B¥ -11.30B¥ 1.81B
Operating Cash Flow¥ 52.47B¥ 55.17B¥ 54.43B¥ 32.19B¥ 27.88B
Investing Cash Flow¥ -55.45B¥ -57.33B¥ -49.11B¥ -43.72B¥ -19.38B
Financing Cash Flow¥ 7.72B¥ 8.53B¥ 3.25B¥ -6.22B¥ -5.51B
Currency in JPY

COSMOS Pharmaceutical Corporation Earnings and Revenue History

COSMOS Pharmaceutical Corporation Debt to Assets

COSMOS Pharmaceutical Corporation Cash Flow

COSMOS Pharmaceutical Corporation Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis